Literature DB >> 12107574

First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions.

Takehiko Yamaguchi1, Minoru Yamato, Koichi Saotome.   

Abstract

The first histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion is presented and the differential diagnosis between benign and malignant notochordal lesions is discussed. A 57-year-old man presented with a classic chordoma in the coccyx. The resected specimen demonstrated a small intraosseous benign notochordal lesion in the coccyx, which was adjacent to the classic chordoma. Also seen were two separate, similar benign lesions in the sacrum. The classic chordoma consisted of multiple lobules that were separated by thin fibrous septa and that showed cords or strands of atypical physaliphorous cells set within an abundant myxoid matrix. In contrast, the benign lesions consisted of intraosseous sheets of bland physaliphorous cells without any extracellular matrix. The affected bone trabeculae showed sclerotic reactions. It was concluded that benign and malignant notochordal lesions can be distinguished microscopically.

Entities:  

Mesh:

Year:  2002        PMID: 12107574     DOI: 10.1007/s00256-002-0514-z

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  29 in total

1.  Chordoma arising from benign multifocal notochordal tumors.

Authors:  Abdulrehman Arain; Francis John Hornicek; Joseph H Schwab; Ivan Chebib; Timothy A Damron
Journal:  Skeletal Radiol       Date:  2017-08-03       Impact factor: 2.199

Review 2.  Notochord to Nucleus Pulposus Transition.

Authors:  Lisa Lawson; Brian D Harfe
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

3.  Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.

Authors:  Dilys M Parry; Mary L McMaster; Norbert J Liebsch; Nicholas J Patronas; Martha M Quezado; Deborah Zametkin; Xiaohong R Yang; Alisa M Goldstein
Journal:  J Neurosurg       Date:  2020-06-19       Impact factor: 5.115

Review 4.  Benign notochordal lesions of the axial skeleton: a review and current appraisal.

Authors:  Michael Kyriakos
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

5.  Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.

Authors:  Kang-Wu Chen; Hui-Lin Yang; Jian Lu; Gen-Lin Wang; Yi-Ming Ji; Gui-Zhong Wu; Li-Fan Zhu; Jia-Yong Liu; Xiao-Qing Chen; Yong-Ping Gu
Journal:  J Neurooncol       Date:  2010-06-15       Impact factor: 4.130

6.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

7.  Differentiation of spinal giant cell tumors from chordomas by using a scoring system.

Authors:  Takashi Tsuji; Kazuhiro Chiba; Kota Watanabe; Ken Ishii; Masaya Nakamura; Yuji Nishiwaki; Morio Matsumoto
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-07-22

8.  Paraspinal chordoma mimicking a neurofibroma: a rare but important radiological pitfall.

Authors:  Nikhil Kotnis; John Goepel
Journal:  Skeletal Radiol       Date:  2012-11-15       Impact factor: 2.199

9.  Diagnostic imaging dilemma of a clival lesion and its clinical management implications.

Authors:  Sung-Joo Yuh; John Woulfe; Martin J Corsten; Ricardo L Carrau; Daniel M Prevedello; Amin B Kassam
Journal:  J Neurol Surg B Skull Base       Date:  2014-03-03

10.  A case of paravertebral mediastinal chordoma without bone destruction.

Authors:  Jun Matsubayashi; Eiichi Sato; Masaharu Nomura; Masatoshi Kakihana; Osamu Uchida; Hisashi Saji; Jinho Park; Souichi Akata; Norihiko Ikeda; Toshitaka Nagao; Tsuyoshi Ishida
Journal:  Skeletal Radiol       Date:  2012-08-11       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.